M1 Kliniken AG

  • ISIN: DE000A0STSQ8
  • Land: Deutschland

Nachricht vom 27.02.2018 | 08:30

Growing demand for beauty treatments: M1 Kliniken AG continues growth and opens new specialist centre for aesthetic medicine

DGAP-News: M1 Kliniken AG / Key word(s): Expansion

27.02.2018 / 08:30
The issuer is solely responsible for the content of this announcement.

Growing demand for beauty treatments: M1 Kliniken AG continues growth and opens new specialist centre for aesthetic medicine

- Second location opened in Munich and moved into larger location in Frankfurt am Main
- Number of specialist centres increased from 11 to 17 in 2017
- Numerous further specialist centres and start of international expansion planned

Berlin, 27.02.2018 - The demand for plastic and aesthetic beauty treatments in Germany has also risen in 2017. This benefits M1 Kliniken AG (ISIN: DE000A0STSQ8), which is the number one in the field of beauty medicine in Germany under its "M1 Med Beauty" brand. In 2017 alone, the number of specialist centres in Germany increased by more than 50% from 11 to 17. Treatments also increased significantly last year from 100,000 in 2016 to more than 150,000 - and the trend continues to rise sharply.

The Group continues to grow in the first few weeks of the new year. M1 Med Beauty opened its second specialist centre in Munich. In addition to the previous location in Schwabing, M1 now operates a further centre with experienced specialists for all questions relating to aesthetic medicine and plastic surgery at the location Stachus (Sonnenstraße 11). In addition, the specialist centre in Frankfurt am Main has moved to Schillerstraße. The reason: The high demand can be better served in larger premises.

"We are very pleased with the strong demand for our high-quality treatments. It shows that our specialisation in selected aesthetic and plastic treatments is the right strategy. We will continue our growth course in the current year - and beyond - and open numerous new locations," says Patrick Brenske, member of the management board of M1 Kliniken AG. "With the opening of our first specialist centre outside Germany, we also intend to start our international expansion in 2018."

About M1 Kliniken AG
M1 Kliniken AG is the leading private provider of health care services in the field of beauty medicine in Germany. In the aesthetic and surgical field, the Group offers products and services of the highest quality standard. Under the brand name "M1 Med Beauty", a network of currently 18 specialist centres for beauty treatments and a surgical clinic is operated. With six operating theatres and 35 beds, the Schlossklinik für Plastische und Ästhetik Chirurgie in Berlin is one of the largest and most modern facilities of its kind in Europe. The Group also markets high-quality products to doctors, pharmacies and wholesalers. www.m1-kliniken.de/en

Details of the M1 Kliniken AG share
Subscribed capital: EUR 16,500,000
Class of shares: Bearer shares
ISIN: DE000A0STSQ8 * WKN: A0STSQ * Stock exchange symbol: M12

M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 887 086 225
M: ir@m1-kliniken.de


27.02.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

GBC im Fokus

UniDevice AG mit hoher Ergebnisdynamik

Die UniDevice AG weist zum Halbjahr eine hohe Umsatz- und Ergebnisdynamik auf. Der Börsenneuling agiert als Schnittstelle zwischen Distributoren und Groß- und Einzelhändler von elektronischen Geräten (vornehmlich Smartphones) und profitiert daher von der zunehmenden Nachfrage in diesem Bereich. Für 2018 peilt UniDevice die Umsatzmarke von 300 Mio. € an. Die GBC-Analysten stufen die Aktie mit einem Kursziel von 2,30 € und KAUFEN ein.

Aktueller Webcast

EQS Group AG

Half-yearly financial statements 2018

16. August 2018

Aktuelle Research-Studie


Original-Research: KPS AG (von GBC AG): BUY

14. August 2018